Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
TATA Health International Holdings Ltd. ( (HK:1255) ) has issued an announcement.
TATA Health International Holdings Limited has announced significant changes in its board and executive team. The company has accepted the resignations of Mr. Wang Jian as an independent non-executive director and chairman of several committees, Mr. Lin Zheming as a non-executive director, and Mr. Lai Wenjing as the chief financial officer, all effective from September 3, 2025. These resignations are due to the individuals’ decisions to focus on other work commitments. Ms. Huang Lin has been appointed to replace Mr. Wang in his committee roles. However, the company now faces non-compliance with Rule 3.10(2) of the Listing Rules, as it currently lacks an independent non-executive director with the necessary professional qualifications or financial expertise.
More about TATA Health International Holdings Ltd.
Technical Sentiment Signal: Sell
Current Market Cap: HK$72.85M
See more insights into 1255 stock on TipRanks’ Stock Analysis page.